National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 52479 [2021-20370]
Download as PDF
<![CDATA[
Federal Register / Vol. 86, No. 180 / Tuesday, September 21, 2021 / Notices
Sherrette A. Funn,
Paperwork Reduction Act Reports Clearance
Officer, Office of the Secretary.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2021–20324 Filed 9–20–21; 8:45 am]
National Institutes of Health
National Institutes of Health
Office of the Director, National
Institutes of Health; Notice of Meeting
National Institute of Mental Health
(NIMH); Notice of Meeting
BILLING CODE 4150–32–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Tropical Medicine Research
Centers (U01 Clinical Trial Not Allowed).
Date: October 18–19, 2021.
Time: 10:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G62A,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Eleazar Cohen, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 3G62A, Rockville, MD
20852, (240) 669–5081, ecohen@
niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
lotter on DSK11XQN23PROD with NOTICES1
52479
Dated: September 15, 2021.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–20370 Filed 9–20–21; 8:45 am]
BILLING CODE 4140–01–P
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the NIH Clinical Center
Research Hospital Board.
The meeting will be held as a virtual
meeting and open to the public.
Individuals who plan to view the virtual
meeting and need special assistance or
other reasonable accommodations to
view the meeting should notify the
Contact Person listed below in advance
of the meeting. The meeting can be
accessed from the NIH video https://
videocast.nih.gov/ and the CCRHB
website https://ccrhb.od.nih.gov/
meetings.html.
Name of Committee: NIH Clinical Center
Research Hospital Board.
Date: October 15, 2021.
Time: 9:00 a.m. to 1:00 p.m.
Agenda: CC CEO Update, Patient Safety
and Clinical Quality Update, other business
of the Board.
Place: National Institutes of Health,
Building 1, 9000 Rockville Pike, Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Gretchen Wood, Staff
Assistant, National Institutes of Health,
Office of the Director, One Center Drive,
Building 1, Room 126, Bethesda, MD 20892,
301–496–4272, woodgs@od.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
Dated: September 15, 2021.
Patricia B. Hansberger,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
[FR Doc. 2021–20369 Filed 9–20–21; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
21:03 Sep 20, 2021
Jkt 253001
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Interagency Autism
Coordinating Committee.
The purpose of the IACC meeting is
to discuss business, agency updates, and
issues related to autism spectrum
disorder (ASD) research and services
activities. The meeting will be held as
a virtual meeting and is open to the
public. Individuals who plan to view
the virtual meeting and need special
assistance or other reasonable
accommodations to view the meeting
should notify the Contact Person listed
below at least seven (7) business days in
advance of the meeting. The open
session will be videocast and can be
accessed from the NIH Videocast
website (https://videocast.nih.gov/).
Name of Committee: Interagency Autism
Coordinating Committee (IACC).
Date: October 13–14, 2021 Meeting
schedule subject to change.
Time: 1:00 p.m. to 5:00 p.m.
Meeting Access: Wednesday, October 13,
2021 https://videocast.nih.gov/watch=42377
Thursday, October 14, 2021 https://videocast.
nih.gov/watch=42378.
Agenda: To discuss business, updates, and
issues related to ASD research and services
activities.
Cost: The meeting is free and open to the
public.
Registration: A registration web link will
be posted on the IACC website
(www.iacc.hhs.gov) prior to the meeting. Preregistration is recommended.
Deadlines: Written/Virtual Public
Comment Due Date: Friday, October 1, 2021,
by 5:00 p.m. ET, For instructions, see below.
Contact Person: Ms. Rebecca Martin, Office
of Autism Research Coordination, National
Institute of Mental Health, NIH, 6001
Executive Boulevard, Bethesda, MD 20892–
9669, Phone: 301–435–0886, Email:
IACCPublicInquiries@mail.nih.gov.
Public Comments
The IACC welcomes public comments
from members of the autism
community. As the IACC will be
updating its Strategic Plan, comments
related to issues that the community
would like to see highlighted in the new
IACC Strategic Plan are welcome.
Comments may be submitted in writing
via email to IACCPublicInquiries@
mail.nih.gov or using the web form at:
https://iacc.hhs.gov/meetings/publiccomments/submit/index.jsp by 5:00
p.m. ET on Friday, October 1, 2021. A
limited number of slots are available for
E:\FR\FM\21SEN1.SGM
21SEN1
]]>Agencies
[Federal Register Volume 86, Number 180 (Tuesday, September 21, 2021)]
[Notices]
[Page 52479]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-20370]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; Tropical Medicine Research Centers
(U01 Clinical Trial Not Allowed).
Date: October 18-19, 2021.
Time: 10:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Room 3G62A,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Eleazar Cohen, Ph.D., Scientific Review Officer,
Scientific Review Program, Division of Extramural Activities,
National Institute of Allergy and Infectious Diseases, National
Institutes of Health, 5601 Fishers Lane, Room 3G62A, Rockville, MD
20852, (240) 669-5081, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: September 15, 2021.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-20370 Filed 9-20-21; 8:45 am]
BILLING CODE 4140-01-P
